Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T20:49:39.013Z Has data issue: false hasContentIssue false
  • English
  • Français

Insulin-like growth factor-1 and lipoprotein profile in cord blood of preterm small for gestational age infants

Published online by Cambridge University Press:  28 August 2013

N. Nagano ,
T. Okada ,
R. Fukamachi ,
K. Yoshikawa ,
S. Munakata ,
Y. Usukura ,
S. Hosono ,
S. Takahashi ,
H. Mugishima  and
M. Matsuura
...Show all authors
N. Nagano
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
T. Okada*
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
R. Fukamachi
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
K. Yoshikawa
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
S. Munakata
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
Y. Usukura
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
S. Hosono
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
S. Takahashi
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
H. Mugishima
Affiliation:
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan
M. Matsuura
Affiliation:
Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan
T. Yamamoto
Affiliation:
Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo, Japan
*
*Address for correspondence: T. Okada MD, Department of Pediatrics and Child Health, Nihon University School of Medicine30-1 Oyaguchi Kamicho, Itabashi-ku, Tokyo 173-8610, Japan. (Email [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Low birth weight was associated with cardiometabolic diseases in adult age. Insulin-like growth factor-1 (IGF-1) has a crucial role in fetal growth and also associates with cardiometabolic risks in adults. Therefore, we elucidated the association between IGF-1 level and serum lipids in cord blood of preterm infants. The subjects were 41 consecutive, healthy preterm neonates (27 male, 14 female) born at <37-week gestational age, including 10 small for gestational age (SGA) infants (<10th percentile). IGF-1 levels and serum lipids were measured in cord blood, and high-density lipoprotein cholesterol (HDLC), low-density lipoprotein cholesterol (LDLC) and very low-density lipoprotein triglyceride (VLDLTG) levels were determined by HPLC method. SGA infants had lower IGF-1 (13.1 ± 5.3 ng/ml), total cholesterol (TC) (55.0 ± 14.8), LDLC (21.6 ± 8.3) and HDLC (26.3 ± 11.3) levels, and higher VLDLTG levels (19.0 ± 12.7 mg/dl) than in appropriate for gestational age (AGA) infants (53.6 ± 25.6, 83.4 ± 18.9, 36.6 ± 11.1, 38.5 ± 11.6, 8.1 ± 7.0, respectively). In simple regression analyses, log IGF-1 correlated positively with birth weight (r = 0.721, P < 0.001), TC (r = 0.636, P < 0.001), LDLC (r = 0.453, P = 0.006), and HDLC levels (r = 0.648, P < 0.001), and negatively with log TG (r = −0.484, P = 0.002) and log VLDL-TG (r = −0.393, P = 0.018). Multiple regression analyses demonstrated that IGF-1 was an independent predictor of TC, HDLC and TG levels after the gestational age and birth weight were taken into account. In preterm SGA infants, cord blood lipids profile altered with the concomitant decrease in IGF-1 level.

Keywords

high-density lipoproteininsulin-like growth factor-1neonate
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 4 , Issue 6 , December 2013 , pp. 507 - 512
Copyright
Copyright © Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Wollmann, HA. Growth hormone and growth factors during perinatal life. Horm Res. 2000; 53(Suppl 1), 50–54.Google Scholar
2.Suwa, S, Katsumata, N, Maesaka, H, et al. Serum insulin-like growth factor I (somatomedin-C) level in normal subjects from infancy to adulthood, pituitary dwarfs and normal variant short children. Endocrinol. 1988; 35, 857–864.Google Scholar
3.Woods, KA, Camacho-Hubner, C, Savage, MO, et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996; 335, 1363–1367.Google Scholar
4.Camacho-Hübner, C, Woods, KA, Miraki-Moud, F, et al. Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy. Growth Horm IGF Res. 1999; 9(Suppl B), 47–52.Google Scholar
5.Takahashi, Y. Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. Endocr J. 2012; 59, 955–962.Google Scholar
6.Conti, E, Musumeci, MB, De Giusti, M, et al. IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clin Sci. 2011; 120, 377–402.Google Scholar
7.Ungvari, Z, Csiszar, A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol A Biol Sci Med Sci. 2012; 67, 599–610.Google Scholar
8.Colao, A, Spiezia, S, Di Somma, C, et al. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age. J Endocrinol Invest. 2005; 28, 440–448.Google Scholar
9.Succurro, E, Arturi, F, Grembiale, A, et al. Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. Eur J Endocrinol. 2010; 163, 75–80.Google Scholar
10.Zenobi, PD, Holzmann, P, Glatz, Y, et al. Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia. 1993; 36, 465–469.Google Scholar
11.Nelson, SM, Freeman, DJ, Sattar, N, et al. IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes. Diabetes. 2007; 56, 2705–2709.Google Scholar
12.Guilloteau, P, Zabielski, R, Hammon, HM, et al. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol. 2009; 60(Suppl 3), 17–35.Google ScholarPubMed
13.Hanley, B, Dijane, J, Fewtrell, M, et al. Metabolic imprinting, programming and epigenetics – a review of present priorities and future opportunities. Br J Nutr. 2010; 104(Suppl 1), S1–S25.Google Scholar
14.Tosh, DN, Fu, Q, Callaway, CW, et al. Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal catch-up growth. Am J Physiol Gastrointest Liver Physiol. 2010; 299, G1023–G1029.Google Scholar
15.Fu, Q, Yu, X, Callaway, CW, et al. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J. 2009; 23, 2438–2449.Google Scholar
16.Itabashi, K, Fujimura, M, Kusuda, S, et al. Committee on Neonatal Medicine in Japan Pediatric Society. New neonatal anthropometric charts. J Jpn Pediatr Soc. 2010; 114, 1271–1293 (in Japanese).Google Scholar
17.Okazaki, M, Usui, S, Ishigami, M, et al. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography. Arterioscler Thromb Vasc Biol. 2005; 25, 578–584.CrossRefGoogle ScholarPubMed
18.Sakurabayashi, I, Saito, Y, Kita, T, et al. Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level. Clin Chim Acta. 2001; 12, 87–95.Google Scholar
19.Bansal, N, Cruickshank, JK, McElduff, P, et al. Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol. 2005; 16, 400–408.Google Scholar
20.Nagano, N, Okada, T, Yonezawa, R, et al. Early postnatal changes of lipoprotein subclass profile in late preterm infants. Clin Chim Acta. 2012; 413, 109–112.Google Scholar
21.Kelishadi, R, Badiee, Z, Adeli, K. Cord blood lipid profile and associated factors: baseline data of a birth cohort study. Paediatr Perinat Epidemiol. 2007; 21, 518–524.Google Scholar
22.Cai, HJ, Xie, CL, Chen, Q, et al. The relationship between hepatic low-density lipoprotein receptor activity and serum cholesterol level in the human fetus. Hepatology. 1991; 13, 852–857.Google Scholar
23.Diaz, M, Leal, C, Ramon, Y, et al. Cord blood lipoprotein-cholesterol: relationship birth weight and gestational age of newborns. Metabolism. 1989; 38, 435–438.Google Scholar
24.Lok, F, Owens, JA, Mundy, L, et al. Insulin-like growth factor I promotes growth selectively in fetal sheep in late gestation. Am J Physiol. 1996; 270(Pt 2), R1148–R1155.Google Scholar
25.Fowden, AL. The insulin-like growth factors and feto-placental growth. Placenta. 2003; 24, 803–812.Google Scholar
26.Ross, JT, McMillen, IC, Lok, F, et al. Intrafetal insulin-like growth factor-I infusion stimulates adrenal growth but not steroidogenesis in the sheep fetus during late gestation. Endocrinology. 2007; 148, 5424–5432.Google Scholar
27.Parker, CR Jr, Carr, BR, Simpson, ER, et al. Decline in the concentration of low-density lipoprotein-cholesterol in human fetal plasma near term. Metabolism. 1983; 32, 919–923.Google Scholar
28.Kaser, S, Ebenbichler, CF, Wolf, HJ, et al. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Metabolism. 2001; 50, 723–728.Google Scholar
29.Loukidi-Bouchenak, B, Lamri-Senhadji, MY, Merzouk, S, et al. Serum lecithin: cholesterol acyltransferase activity, HDL2 and HDL3 composition in hypertensive mothers and their small for gestational age newborns. Eur J Pediatr. 2008; 167, 525–532.Google Scholar
30.Yoshikawa, K, Okada, T, Munakata, S, et al. Association between serum lipoprotein lipase mass concentration and subcutaneous fat accumulation during neonatal period. Eur J Clin Nutr. 2010; 64, 447–453.Google Scholar
31.Kajantie, E, Barker, DJ, Osmond, C, et al. Growth before 2 years of age and serum lipids 60 years later: the Helsinki Birth Cohort study. Int J Epidemiol. 2008; 37, 280–289.Google Scholar
32.Jensen, RB, Chellakooty, M, Vielwerth, S, et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role? Horm Res. 2003; 60(Suppl 3), 136–148.Google Scholar
33.IJzerman, RG, Stehouwer, CD, Van Weissenbruch, MM, et al. Evidence for genetic factors explaining the association between birth weight and low-density lipoprotein cholesterol and possible intrauterine factors influencing the association between birth weight and high-density lipoprotein cholesterol: analysis in twins. J Clin Endocrinol Metab. 2001; 86, 5479–5484.Google Scholar
34.Colangelo, LA, Liu, K, Gapstur, SM, CARDIA Male Hormone Study. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: the CARDIA Male Hormone Study. Am J Epidemiol. 2004; 160, 750–757.Google Scholar
Supplementary material: File

Nagano Supplementary Material

Table

Download Nagano Supplementary Material(File)
File 46.6 KB